NEW ORLEANS - An experimental drug is the first to substantially and safely improve shortness of breath and other symptoms in people hospitalized with severe heart failure, an epidemic that is growing as baby boomers age, doctors reported Sunday.
However, many were disappointed that the drug also did not help people live longer or stay out of the hospital.
"What we really need are therapies that are going to improve the outcome," said Dr. Gregg Fonarow, an American Heart Association spokesman from the University of California at Los Angeles.
He had no role in the study, which was led by Dr. Marvin Konstam of Tufts-New England Medical Center and presented at an …
Комментариев нет:
Отправить комментарий